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Abstract:  We present  a snapshot hyperspectral retinal camera with the 
Image Mapping Spectrometer (IMS) for eye imaging applications. The 
resulting system is capable of simultaneously acquiring 48 spectral channel 
images in the range 470 nm–650 nm with frame rate at 5.2 fps. The spatial 
sampling of each measured spectral scene is 350 × 350 pixels. The 
advantages of this snapshot device are elimination of the eye motion 
artifacts and pixel misregistration problems in traditional scanning-based 
hyperspectral retinal cameras, and real-time imaging of oxygen saturation 
dynamics with sub-second temporal resolution. The spectral imaging 
performance is demonstrated in a human retinal imaging experiment in vivo. 
The absorption spectral signatures of oxy-hemoglobin and macular 
pigments were successfully acquired by using this device. 
© 2011 Optical Society of America 
OCIS codes: (110.4234) Multispectral and hyperspectral imaging; (170.6510) Spectroscopy, 
tissue diagnostics; (330.4460) Ophthalmic optics and devices. 
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1. Introduction 
Hyperspectral retinal imaging is a novel technique for non-invasive ocular diagnosis [1,2]. 
Instead of only providing intensity images, the hyperspectral retinal camera is capable of 
acquiring both spatial and spectral retinal information and constructing an (x,  y,  λ) 3D 
datacube for multivariable data analysis [3,4]. Since light reflected from retinal structures (e. 
g., the macula) often have unique spectral signatures which are commonly considered to be 
associated with specific ocular diseases [5], the capability of identifying these spectral 
signatures in-vivo will be of high value in clinical diagnosis and treatment. However, most 
traditional hyperspectral retinal cameras are scanning-based systems—they either scan in the 
spatial  domain, e.g. push-broom slit scanning spectrometers [1], or scan in the spectral 
domain, e.g., liquid-crystal-tunable-filters [6] and sequential illuminated multicolor LEDs [7]. 
Incorporation of scanning-based hyperspectral imagers in retinal imaging causes severe 
motion artifacts and pixel misregistration problems because the human eye is constantly 
moving. To overcome this limitation, recently a snapshot hyperspectral retinal camera which 
utilizes a computed tomographic imaging spectrometer (CTIS) has been developed for fundus 
imaging [8]. Although this CTIS-based hyperspectral retinal camera can acquire multiple 
spectral scenes within a single integration event, the CTIS technique itself requires extensive 
computational cost and is limited by resolution constraints [9]. 
In this article, we present a novel snapshot hyperspectral retinal camera which uses an 
Image Mapping Spectrometer (IMS) [10–12] as its spectrum detector. The IMS is a parallel 
acquisition hyperspectral imager that can capture hyperspectral datacubes without scanning. It 
also allows full light throughput across the whole spectral collection range due to its snapshot 
operating format. By integrating the IMS with a traditional retinal camera (Topcon TRC50X, 
Topcon Inc, Tokyo, Japan), we have achieved simultaneous 48 spectral channel imaging of 
the human retina in vivo. The reflectance and absorption spectra from vessels and the macula 
were measured, from which the known spectral absorption signatures of oxy-hemoglobin and 
macular pigment were successfully identified. The previously unknown spectral reflectance of 
an optic disc druse was also measured. 
2. System description 
The system setup of the hyperspectral retinal camera is shown in Fig. 1 (a). The IMS is 
coupled to the back image port of the Topcon TRC 50X retinal camera to acquire (x, y, λ) 
datacubes. The optical components of the retinal camera and the IMS are shown in Fig. 1 (b). 
The illumination is provided by the tungsten light of retinal camera. After being collimated, 
the illumination light is reflected by an annular mirror and then focused on to the eye’s pupil, 
creating a uniformly illuminated field on the retina. The reflected light from the fundus is 
collected by retinal camera’s front lens and forms an intermediate image at its back image 
port, where the entrance port of the IMS is co-located. 
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detailed elsewhere [10,11]. Briefly, the intermediate image at the entrance port is first 
reimaged onto a custom-fabricated component—the image mapper. The image mapper 
consists of hundreds of mirror facets, and each mirror facet is around 70 µm wide and has a 
two-dimensional tilt [13]. The image mapper cuts the intermediate image into strips and 
reflects them to different locations of a CCD camera. Due to tilt angle differences of mirror 
facets on the image mapper, blank regions are created between adjacent image strips at the 
detector plane. The strips of reflected light from the image mapper are then dispersed by a 
prism array and reimaged onto their associated blank regions by an array of reimaging lenses. 
In this way, each pixel on the CCD camera is encoded with unique spatial and spectral 
information from the sample. By applying a simple image remapping algorithm [11], a 
hyperspectral (x, y, λ) datacube is acquired. Since no scanning is employed, the IMS features 
high optical throughput and datacube acquisition rate (currently up to 7.2 fps [12]). The 
spatial sampling of each acquired spectral scene is 350 × 350 pixels, and the measured 
spectral range is from 470 nm to 650 nm with ~4 nm bandwidth. 
 
Fig. 1. Snapshot hyperspectral retinal camera with the IMS. The IMS is coupled to the back 
image port of a traditional retinal camera. The optical layout inside the IMS is detailed in [12]. 
3. Hyperspectral imaging of the retina in vivo 
To demonstrate the spectral imaging performance of the IMS-based hyperspectral retinal 
camera, the retina of a 25 year old healthy female volunteer with a known ocular diagnosis of 
optic disc drusen [14] was imaged in vivo. The subject’s pupil was dilated with mydriatic 
(Mydriacyl, 1%) 15 minutes before the experiment. The hyperspectral retinal camera was 
working in the reflectance imaging mode, in which the internal light source of the retinal 
camera provided constant illumination of the structures. The retinal images were taken at the 
50 degree viewing angle of the camera, of which an approximately 20 degree retinal image 
was captured by the optics of the IMS. The IMS was operated at 5.2 fps with ~180 ms 
integration time for each frame. The acquired (x, y, λ) datacube is displayed as a panchromatic 
image in Fig. 2 (a). The coloration of each pixel is converted from corresponding spectral data 
with a specific algorithm [15]. Selected images from a total of 48 spectral channels are shown 
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show up in Media 1. These stripes are image artifacts and are caused by the mirror facets’ 
reflectivity variations in the current IMS. In order to provide a baseline reference, a retinal 
camera image without the IMS attached is also captured and shown in Fig. 2(c). The image 
resolution of the standard fundus photo is about the same as the hyperspectral composite. 
 
Fig. 2. Hyperspectral imaging of the retina centered at the optic disc in vivo. An optic disc 
drusen is seen at about the one o’clock position at the edge of the disc. (a) Panchromatic image 
display  of  acquired  (x,  y,  λ)  datacube.  The  coloration  of  each  pixel  is  converted  from 
corresponding spectral data. (b) Selected images from a total of 48 spectral channels. A scan of 
all acquired wavelengths is shown in Media 1. Note the greater spectral reflectance of the optic 
disc druse in the 530 nm to 580 nm wavelengths. There is also an atypical retinal vessel 
branching pattern, which often accompanies optic disc drusen. (c) Baseline reference image 
captured without the IMS attached. 
The ability to visualize oxygen delivery into the eye in vivo is important in clinical studies 
because it would aid our understanding of the way that oxygen is provided and used in the 
eye, both in healthy and diseased conditions. Since the oxygenation can be estimated from 
blood oxy-hemoglobin concentration [1], we first measured the absorption spectra from a 
retinal arteriole on the optic nerve (see Fig. 3) to test the feasibility of the proposed system in 
recovering oxy-hemoglobin’s absorption spectral signature. The IMS was spectrally calibrated 
with respect to a standard light source (Ocean optics, PN: LS-1-CAL-INT) before the 
experiment. The spectral range from 510 nm to 586 nm was chosen for analysis because 
within this range the blood absorption has a major contribution to the overall spectral 
reflection while ocular media absorption and scattering by erythrocytes are minimal [4,16]. 
The reflectance spectrum Sr (Fig. 3(b)) at the vessel was acquired by averaging over pixels’ 
spectra in the circled area. In order to acquire the absorption spectrum in the same area, the 
lamp’s illumination spectrum Si was first measured by placing a white paper in front of the 
retinal camera’s front lens and averaging over pixels’ reflectance spectra in the field of view. 
Then the absorption spectrum Sa (Fig. 3(c)) was calculated by subtracting the normalized 
reflectance spectrum Sr from the normalized lamp’s illumination spectrum Si in the spectral 
range 510 nm to 586 nm, e.g. 
 
510 586 510 586 510 586 510 586 510 586 / max( ) / max( )
nm nm nm nm nm
ai i r r S SS SS
− −− −− =−    (1) 
The two dominant peaks in the resulting spectrum (Fig. 3(c)) correspond to the peak 
absorptions of oxy-hemoglobin at around 540 nm and 570 nm, as expected from an arteriole 
with nearly completely O2 saturated hemoglobin [1]. Additionally, since our subject carries a 
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reflectance spectrum of one druse relative to the reflectance of normal disc substance (position 
C in Fig. 3(a)). The measured reflectance spectra of the druse and normal disc substance are 
shown in Fig. 3(d) and their ratio vs. wavelength is calculated and shown in Fig. 3(e). These 
results indicate that the druse is more reflective than the normal disc substance in the 530 nm 
to 580 nm range. Note that ordinary macular soft drusen studied with a previous CTIS 
hyperspectral system also showed a reflectance peak around 560 nm [17], consistent with a 
similar biochemical composition of the two types of drusen. 
 
Fig. 3. Measured (b) reflectance spectrum and (c) absorption spectrum of oxy-hemoglobin in a 
retinal arteriole on the optic nerve; measured (d) reflectance spectra of druse and normal disc 
substance and (e) their reflectance ratio vs. wavelength 
A time-lapsed video of oxygen saturation dynamics was then recorded with a frame rate of 
5.2 fps. The oxygen saturation map (see Fig. 4) was calculated at each scene with the 
algorithm detailed in Refs. [1,18]. The oxygen saturation dynamics at one arteriole (pointer, 
Fig. 4) is shown in Fig. 5. These results show that the relative saturation index value reaches 
its maximum at time t = 720 ms and t = 2340 ms, an interval of 1.6 sec. Interestingly, the 
subject’s pulse of 72 bpm would suggest that the O2 saturation should peak about every 0.84 
sec, or about twice as often as measured herein. A possible explanation may lie in the 
anomalous circulation on the optic disc in subjects with optic disc drusen [14,19], and in fact 
the central retinal artery can be bypassed completely [19], but this of course is speculation. 
Note that during the acquisition period, the eye was constantly moving (Media 2). Since 
current scanning-based hyperspectral retinal cameras normally require an exposure time > 5 
secs long to acquire an (x, y, λ) datacube [20], all in vivo retinal data from such systems would 
be compromised by motion artifacts. In particular, a dynamic study such as seen in Figs. 4 and 
5 would not even be possible. 
Next we measured the absorption spectra of macular pigment (MP) in the central macula 
(see Fig. 6). Previous studies have shown that accurately mapping MP optical density and 
characterizing its biochemical nature would be instrumental in understanding the role of MP  
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Fig. 4. Oxygen saturation dynamics near the optic nerve (Media 2) 
 
Fig. 5. Relative saturation index vs. time at an arteriole on the optic nerve 
in age-related macular degeneration [5,21]. Using the absorption spectrum of MP is widely 
considered as a clinically applicable and accessible tool in MP quantification [21]; however, 
few experiments can fully implement this measurement in vivo—they are either restricted in 
spatial extent to single line scans [22] or spectrally to a limited number of spectral bands [23]. 
Here we demonstrated that the proposed system is capable of measuring the absorption 
spectrum of MP non-invasively. In the experiment, a field-of-view in the central macula (Fig. 
6 (a)) was acquired by the hyperspectral retinal camera with a single snapshot. The spectral 
range 475 nm–520 nm was chosen for MP’s absorption spectrum analysis because previous 
studies indicated that MP has an absorption peak in this spectral range and is almost zero  
 
 
Fig. 6. Measured absorption spectrum of macular pigment. (a) Panchromatic image display of 
acquired (x, y, λ) datacube. (b) Absorption spectrum at circle area A. 
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subtracting the measured normalized reflectance spectrum from the normalized lamp’s 
illumination spectrum in the range 475 nm–520 nm and averaging over pixels in the circled 
area. The resulting absorption spectrum, with a peak around 490 nm in Fig. 6 (b) and which 
also drops to zero beyond 500 nm, is consistent with (although not identical to) previous 
measurements in vitro [5]. The direct recovery of the MP absorption signature by the 
proposed system thus provides a simple approach for characterizing MP in vivo. Note that the 
other MP absorption peak around 460 nm [5] was not detected because it is blocked by a 470 
nm long-pass filter inside the IMS and thus located outside the measured spectral range of the 
current system. 
4. Conclusions 
In summary, we present an IMS-based hyperspectral retinal camera which can acquire an (x, 
y,  λ) datacube of the retina in a single snapshot. Since no scanning is employed, this 
hyperspectral retinal camera does not suffer motion artifacts or pixel misregistration problems 
which are inevitable in scanning-based hyperspectral retinal cameras. The acquisition of 
multichannel retinal images and the recovery of the spectral signatures of oxy-hemoglobin, 
macular pigment and optic disc drusen demonstrated the capability of this device in eye 
imaging applications. To the best of our knowledge, this is the first report of the spectral 
reflectance of optic disc drusen; combined with previous work on the spectral signature of 
macular soft drusen in age-related macular degeneration (AMD), it is compatible with 
biochemically similar components of the two species. Additionally, for the first time we have 
successfully monitored oxygen saturation dynamics in vivo  with sub-second temporal 
resolution. Such dynamic data would be of crucial value for physicians who need to monitor 
improvement or setbacks in retinal oxygenation after therapies directed towards retinal 
vascular diseases. To implement this hyperspectral retinal camera in clinical diagnosis, trials 
are underway at the Harkness Eye Institute in Columbia University to correlate observed 
retinal spectral signatures with specific ocular diseases, particularly retinal vascular disease 
and the drusen of AMD, and establish a significant patient database for future non-invasive 
ophthalmological diagnosis. 
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